Photo of Joni Ernst
R United States Senate · Iowa

Sen. Joni Ernst

Compare
Total votes
1,044
all sessions
Attendance
99%
12 missed
Near the chamber average
With party
95%
of cast votes
Near the chamber average
Bipartisan score
3%
crosses aisle rarely
Near the chamber average
Sponsored
1,178
bills & resolutions
Near the chamber average
Committees
12
assignments
1,178 bills and resolutions

Sponsored bills

Total
1,178
Primary
256
Co-sponsor
922
This page
1,178
matching current filters
Co-sponsor S 3380
In committee Dec 14, 2021 1 co-sponsor
Co-sponsor S 3382
In committee · Indiana Senate · Co-sponsor
Protecting Access to Credit for Small Businesses Act

Protecting Access to Credit for Small Businesses Act This bill prohibits the Small Business Administration from directly making a loan under the 7(a) Program, which authorizes loans and loan guaranties to small businesses that meet certain requirements.

In committee Dec 14, 2021 1 co-sponsor
Co-sponsor SJRES 29
Passed · Indiana Senate · Co-sponsor
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Labor relating to "COVID-19 Vaccination and Testing; Emergency Temporary Standard".

This joint resolution nullifies a Department of Labor emergency temporary standard for preventing the transmission of COVID-19 in employment settings. Under the standard issued on November 5, 2021, employers with 100 or more employees must require their onsite employees to either be fully vaccinated against COVID-19 or undergo weekly COVID-19 testing.

Passed Dec 9, 2021 1 co-sponsor
Co-sponsor S 1428
In committee · Indiana Senate · Co-sponsor
Preserve Access to Affordable Generics and Biosimilars Act

Preserve Access to Affordable Generics and Biosimilars Act This bill authorizes the Federal Trade Commission (FTC) to initiate proceedings against parties to any agreement resolving or settling a patent infringement claim in connection with the sale of a drug or biological product. Such an agreement is presumed to have anticompetitive effects and is a violation of this bill if the filer of the generic drug or biosimilar application receives anything of value and agrees to limit or forego research, development, manufacturing, marketing, or sales of the generic drug or biosimilar. An agreement is exempted if the only consideration granted to the generic manufacturer is (1) the right to market and secure final approval for its product prior to the expiration of any statutory exclusivity, (2) a payment for reasonable litigation expenses, or (3) a covenant not to sue on any claim that the generic drug or biosimilar infringes a patent. An agreement is also exempt if the agreement's pro-competitive benefits outweigh the anticompetitive effects. When a generic or biosimilar drug manufacturer enters into an agreement with another drug manufacturer related to the manufacturing, marketing, or sale of a drug, the manufacturers must certify that the material they have given the FTC concerning the agreement contains the complete agreement and any agreements related to that main agreement, including descriptions of any oral agreements or representations. The bill imposes penalties for violations of this bill, including the forfeiture of the 180-day marketing exclusivity period for a generic drug.

In committee Dec 9, 2021 1 co-sponsor
Co-sponsor SRES 470
Passed · Indiana Senate · Co-sponsor
A resolution relating to the death of the Honorable Robert "Bob" J. Dole, former United States Senator for the State of Kansas.

Maddy summaryThis is a ceremonial Senate resolution (SRES 470) commemorating the death of former U.S. Senator Bob Dole of Kansas. It formally expresses the Senate's sorrow, requests the Secretary of the Senate transmit a copy to Dole's family, and directs the Senate to adjourn as a mark of respect. The resolution has no policy or legal effect - it solely serves as a symbolic tribute to Dole's public service career. It does not affect any individuals or enact new laws.

Passed Dec 8, 2021 1 co-sponsor
Co-sponsor S 1425
In committee · Indiana Senate · Co-sponsor
Stop STALLING Act

Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act or the Stop STALLING Act This bill makes it an unfair method of competition to submit an objectively baseless petition to the Food and Drug Administration (FDA) in an attempt to interfere with a competitor's application for market approval of a drug. The bill authorizes the Federal Trade Commission to sue an individual or entity that submits such a petition to the FDA. A party found liable in such a lawsuit shall be subject to civil penalties, such as a fine of up to $50,000 for each day that the FDA spent reviewing the baseless petition.

In committee Dec 8, 2021 1 co-sponsor
Co-sponsor S 3300
In committee · Indiana Senate · Co-sponsor
Protect American Taxpayer Dollars from Illegal Immigration Act

Protect American Taxpayer Dollars from Illegal Immigration Act This bill prohibits expending federal funds for legal settlements to individuals who violated certain laws relating to the proper time and place to enter the United States, if the settlement pertains to claims based on the lawful detention of such an individual as part of a family unit after the individual's entry into the United States at the southern border after January 20, 2017.

In committee Dec 2, 2021 1 co-sponsor
Co-sponsor S 3277
In committee · Indiana Senate · Co-sponsor
Section 401 Certification Act

Section 401 Certification Act The bill provides statutory authority for the rule published on July 13, 2020, by the Environmental Protection Agency (EPA) entitled Clean Water Act Section 401 Certification Rule . Under Section 401 of the Clean Water Act, an applicant for a federal license or permit to conduct an activity that may result in any discharge into navigable waters must also obtain a certification—or waiver of such certification—from a relevant state, intrastate agency, or Indian tribe that the proposed activity will not violate certain water quality requirements of the state or Indian tribe. The rule revised existing regulations, including by limiting the scope of the certification review process as well as the time frame for a state, interstate agency, or Indian tribe to issue a certification.

In committee Nov 30, 2021 1 co-sponsor
Co-sponsor S 3229
In committee · Indiana Senate · Co-sponsor
Cattle Price Discovery and Transparency Act of 2021

Cattle Price Discovery and Transparency Act of 2021 This bill requires the Department of Agriculture (USDA) to take various actions to address transparency in pricing and contract terms in the cattle industry. Among these requirements, USDA must (1) establish regional minimum percentages of cattle that meat packers must procure through negotiated purchases or negotiated grid purchases (i.e., transactions where the price is known and negotiated at the time of the transaction), and (2) maintain a publicly available catalog of contracts offered by meat packers to livestock producers for the purchase of fed cattle.

In committee Nov 17, 2021 1 co-sponsor
Co-sponsor S 1296
In committee · Indiana Senate · Co-sponsor
Daniel J. Harvey Jr. and Adam Lambert Improving Servicemember Transition to Reduce Veteran Suicide Act

Daniel J. Harvey Jr. and Adam Lambert Improving Servicemember Transition to Reduce Veteran Suicide Act This bill requires the Department of Defense (DOD) and the Department of Veterans Affairs (VA) to jointly implement a five-year pilot program to assess the feasibility and advisability of providing specified counseling and services as part of the Transition Assistance Program for members of the Armed Forces as a means of reducing the incidence of suicide among veterans. Specifically, the pilot program would involve a three-hour counseling module and the provision of contact information for a counseling or similar facility in the locality where the veteran intends to reside. Additionally, the participating veterans must submit medical records in connection with their service in the Armed Forces, regardless of whether they intend to file a claim for benefits for a service-connected disability. Under the program, a social worker or behavioral health coordinator from the VA must contact the veteran within 90 days after the member is discharged or released from service to schedule a follow-up appointment. At least 10 DOD Transition Assistance Centers must be jointly selected to carry out the pilot program.

In committee Nov 17, 2021 1 co-sponsor
Showing 871 to 880 of 1,178 bills
Previous 1 … 87 88 89 … 118 Next